Dopamine D-3 and serotonin (5-HT.sub.1A) receptor ligands and im

Details Dopamine D-3 and serotonin (5-HT.sub.1A) receptor ligands and im Dopamine D-3 and serotonin (5-HT.sub.1A) receptor ligands and im

1995-05-19

1997-11-25

Kight, John

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

544 32, 544101, 544 34, 546 80, 546 89, 546110, 549 23, 549404, 564307, 564308, A61K 5104, C07D22100, C07D31100, C07D33504

Patent

active

056909063

ABSTRACT:
Tetralin derivatives, such as 7-hydroxy-2-(N-n-propyl-N-3 '-iodo-2'-propenyl)-amino!tetralin and 8-hydroxy-2-(N-n-propyl-N-3 '-iodo-2'-propenyl)amino-tetralin, are disclosed which have affinity and specificity for dopamine D-3 and/or serotonin 5-HT.sub.1A receptors.

REFERENCES:
patent: 4163063 (1979-07-01), Cannon et al.
patent: 4298591 (1981-11-01), O'Brien, Jr. et al.
patent: 4420480 (1983-12-01), Jones
patent: 4448990 (1984-05-01), Bach et al.
patent: 4500545 (1985-02-01), Bach et al.
patent: 4556676 (1985-12-01), Welch, Jr. et al.
patent: 4564628 (1986-01-01), Horn
patent: 4657925 (1987-04-01), Horn
patent: 4722933 (1988-02-01), Horn
patent: 4845221 (1989-07-01), Stack et al.
patent: 4876284 (1989-10-01), Arvidsson et al.
patent: 4882352 (1989-11-01), Horn
patent: 4885308 (1989-12-01), Horn
patent: 4920227 (1990-04-01), Pelletier et al.
patent: 4931270 (1990-06-01), Horn et al.
patent: 4943428 (1990-07-01), Lucot et al.
patent: 4996226 (1991-02-01), Horn
patent: 5071875 (1991-12-01), Horn et al.
patent: 5086074 (1992-02-01), DeBernardis et al.
patent: 5128362 (1992-07-01), DeBernardis et al.
patent: 5140040 (1992-08-01), DeBernardis et al.
patent: 5286753 (1994-02-01), Schaus et al.
patent: 5298513 (1994-03-01), Scohe et al.
Foulon et al., "Synthesis of lin (trans-7-OH-PIPAT):A New D3 Dop-amine Receptor Ligand", J. Med. Chem. 36:1499-1500 (1993).
Kung et al., "In Vitro Binding of a Novel Dopamine D3 Receptor Ligand", Eur. J. Pharm., 235:165-166 (1993).
Lin et al., "Centrally Acting Serotonergic Agents . . . ", J. Med. Chem., 36:671-682 (1993).
Beart et al, "Radioreceptor Binding Reveals the Potencies of N,N-Disubstituted 2-Aminotetralins as D.sub.2 Dopamine Agonists," Naunyn-Schmiedeberg's Arch. Pharmacol. 336:487-493 (1987).
Foulon et al., "Synthesis of lin (trans-7-OH-PIPAT): A New D3 Dopamine Receptor Ligand", Journal of Medicinal Chemistry 36:1499-1500 (1993).
Johansson, et al., "C3-Methylated 5-Hydroxy-2-(dipropylamino)tetralins: Conformational and Steric Parameters of Importance for Central Dopamine Receptor Activation", J. Med Chem. 30: 1135-1144 (1987).
Karlsson et al., "Improved Preparation, Chromatographic Separation and X-Ray Crystallographic Determination of the Absolute Configuration of the Enantiomers of 8-Hydroxy-2-(dipropylamino)tetralin (8-OH DPAT)", Acta. Chim. Scan B42:231-236 (1988).
Kung, M-P et al., "In Vitro Binding of a Novel Dopamine D.sub.3 Receptor 235:165-166 (1993).
Kung M.-P et al., "The Characterization of IBF as a New Selective Dopamine D-2 Receptor Imaging Agent", J. Nucl. Med. 31:648-654 (1990).
Levesque et al., "Identification, Characterization and Localization of the H!hydroxy-N,N-di-n-propyl-2-aminotetralin," Proc. Natl. Acad. Sci. USA 89:8155-8159 (1992).
McDermed et al., "Synthesis and Dopaminergic Activity of (.+-.)-, (+)-, and (-)-2-Dipropylamino-5-hydroxy-l,2,3,4-tetrahydronaphthalene", J. Med. Chem. 19:547-549 (1976).
McDermed et al., "Synthesis and Pharmacology of Some 2-Aminotetralins. Dopamine Receptor Agonists", J. Med. Chem. 18:362-367 (1975).
Mellin et al., "Central Dopaminergic and 5-Hydroxytryptaminergic Effects of C3-Methylated Derivatives of 8-Hydroxy-2-(di-n-propylamino) tetralin", J. Med. Chem. 31:1130-1140 (1988).
Mulder et al., "Further in vitro and in vivo Studies with the Putative Presynaptic Dopamine Agonist N,N-Dipropyl-7-Hydroxy-2-Aminotetralin," Naunyn-Schmiedenberg's Arch. Pharmacol. 336:494-501 (1987).
Sokoloff, P., et al., "Molecular Cloning and Characterization of a Novel Dopamine Receptor (D.sub.3) as a Target for Neuroleptics," Nature 347:146-151 (1990).
Sokoloff, P., et al., "The Third Dopamine Receptor (D.sub.3) as a Novel Target for Antipsychotics," Biochemical Pharmacology 43:659-666 (1992).
Wickstrom, H., "Centrally Acting Dopamine D2 Receptor Ligands: Agonists," Prog. in Med. Chem. 29:185-216 (1992).
Wise et al., "6- and 8-Hydroxy-3,4-Dihydro-3-(Dipropylamino)-2H-1-Benzopyrans. Dopamine Agonists with Autoreceptor Selectivity", J. Med. Chem. 31: 688-691 (1988).
Arvidsson et al., "8-Hydroxy-2-(di-n- propylamino) tetralin, a New Centrally Acting 5-Hydroxytryptamine Receptor Agonist", J. Med. Chem. 24: 921-923 (1981).
Arvidsson et al., "(+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: A Potent and Highly Stereoselective 5-Hydroxytryptamine Receptor Agonist", J. Med. Chem. 30:2105-2109 (1987).
Asselin et al., "Drug Design via Pharmacophore Identification. Dopaminergic the Dopamine Receptor", J. Med. Chem. 29:648-654 (1986).
Bakthavachalam et al., "Fluorescent Probes for Dopamine Receptors: Synthesis and Characterization of Fluorescein and 7-Nitrobenz-2-oxa-1, 3-diazol-4-yl Conjugates of D-1 and D-2 Receptor Ligands", J. Med. Chem. 34:3235-3241 (1991).
Cannon et al., "1-(Aminomethyl)-6, 7-dihydroxytetralin Derivatives: Synthesis and Assessment of Dopamine-Like Effects", J. Med. Chem. 26:813-816 (1983).
Cannon et al., "Comparison of Biological Effects of N-Alkylated Congeners of .beta.-Phenethylamine Derived from 2-Aminotetralin, 2-Aminoindan, and 6-Aminobenzocycloheptene", J. Med. Chem. 23:745-749 (1980).
Cannon et al., "Introduction of a Putative Dopaminergic Prodrug Moiety into a 6,7-Substitution Pattern Characteristic of Certain 2-Aminotetralin Dopaminergic Agonists", J. Med. Chem. 32:2210-2214 (1989).
DeWald et al., "Synthesis and Dopamine Agonist Properties of (.+-.)-trans-3,4,4a,10b-Tetrahydro-4-propyl-2H, Chem. 33:445-450 (1990).
Duncan et al., "Metabolism of Aminotetralin Analogues in vivo and by Rat Hepatocytes", Biochemical Society Transact.: 1200-1201 (1990).
Grol et al., "5-Oxygenated N-Alkyl- and N,N-Dialkyl-2-amino-1-methyltetralins. Effects of Structure and Stereochemistry on Dopamine-D.sub.2 -Receptor Affinity", J. Pharm. Pharmacol. 43:481-485 (1991). as Potential Irreversible Labels for Bovine Anterior Pituitary D.sub.2 Dopamine Receptors" J. Med. Chem. 30:1879-1887 (1987).
Horn et al., "6,7-Dihydroxy-3-chromanamine: Synthesis and Pharmacological Activity of an Oxygen Isostere of the Dopamine Agonist 6,7-Dihydroxy-2-aminotetralin", J. Med. Chem. 27: 1340-1343 (1984).
Johansson et al., "C1- and C3-Methyl-Substituted Derivatives of 7-Hydroxy-2-(di-n-propylamino)tetralin: Activities at Central Dopamine Receptors", J. Med. Chem. 30: 1827-1837 (1987).
Johansson et al., "Dopaminergic 2-Aminotetralins: Affinities for Dopamine D.sub.2 -Receptors, Molecular Structures, and Conformational Preferences", Molecular Pharmacology 30:258-269 (1986).
Johansson et al., "Novel Dopamine Receptor Agonists and Antagonists with Preferential Action on Autoreceptors", J. Med. Chem. 28:1049-1053 (1985).
Johansson et al., "Resolved cis- and trans-2-Amino-5-methyoxy-1-methyltetralins: Central Dopamine Receptor Agonists and Antagonists", J. Med. Chem. 30:602-611 (1987).
Johansson et al., "Syntheses of 5-, 7-, and 8-Methoxy-3-methyl-2-tetralone", J. Org. Chem. 51: 5252-5258 (1986).
Johansson et al., "Synthesis and Pharmacology of the Enantiomers of cis-7-Hydroxy-3-methyl-2-(dipropylamino)tetralin", J. Med. Chem. 33:2925-2929 (1990). New Class of Dopamine Agonists", J. Med. Chem. 27:1607-1613 (1984).
Langlois and Gaudy, "A New Synthesis of 8-Hydroxy-2-DI-n-Propylamino-Tetralin (8-OH-DPAT)", Synthetic Communications 22:1723-1734 (1992).
Lin et al., "Centrally Acting Serotonergic Agents. Synthesis and Structure-Activity Relationships of C-1- or C-3-Substituted Derivatives of 8-Hydroxy-2-(di-n-propylamino)tetralin", J. Med. Chem. 36:671-682 (1993).
Liu et al., "(R)- and (S)-5,6,7,8-Tetrahydro-1-hydroxy-N,N-dipropyl-9H-benzocyclohepten-8-ylamin e. Stereoselective Interactions with 5-HT.sub.1A Receptors in the Brain", J. Med. Chem. 32:2311-2318 (1989).
Martin et al., "Pharmacologic Profile of a Novel Potent Direct-Acting Pharmacology and Experimental Therapeutics 230:569-576 (1989).
Neumeyer et al., "R and S Enantiomers of 11-Hydroxy- and 10,11-Dihydroxy-N-allylnoraporphine: Synthesis and Affinity for Dopamine Receptors in Rat Brain Tissue", J. Med. Chem. 34:24-28 (1991).
Seiler et al., "Further Characterization of Structural Requirements for Agonists at the Striatal Dopamine D-1 Receptor", Molecular Pharmacology 2

Affiliated with

Also associated with

Rating

Dopamine D-3 and serotonin (5-HT.sub.1A) receptor ligands and im does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dopamine D-3 and serotonin (5-HT.sub.1A) receptor ligands and im, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dopamine D-3 and serotonin (5-HT.sub.1A) receptor ligands and im will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2104302